SciELO - Scientific Electronic Library Online

 
vol.52 número2Clozapine-Induced Eosinophilia: a Case Report índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista Colombiana de Psiquiatría

versão impressa ISSN 0034-7450

Resumo

REVILLA-ZUNIGA, Joshep; CARPIO, Joise Cornejo-Del  e  CRUZADO, Lizardo. Hepatoxicity Induced by Clozapine: Case Report and Brief Review. rev.colomb.psiquiatr. [online]. 2023, vol.52, n.2, pp.165-170.  Epub 15-Ago-2023. ISSN 0034-7450.  https://doi.org/10.1016/j.rcp.2021.04.010.

Introduction:

Antipsychotics are drugs that can produce transient elevations of hepatic enzymes. Clozapine is an atypical antipsychotic used in treatment-resistant schizophrenia and there is evidence that it can produce elevations of hepatic transaminases, expression of liver damage in a hepatocellular pattern.

Methods:

Case report and non-systematic review of the relevant literature.

Case presentation:

A 39-year-old woman with a diagnosis of paranoid schizophrenia attended the emergency department of a general hospital for nausea, vomiting and jaundice that appeared after the initiation of clozapine. There was no clinical improvement during hospitalization, and death occurred after 44 days.

Literature review:

Clozapine can increase the liver enzyme levels transiently and asymptomatically; however, there are clinical criteria that recommend the withdrawal of the antipsychotic.

Conclusions:

This is the third case reported in the literature of a fatal outcome of clozapine-induced hepatotoxicity.

Palavras-chave : Drug-induced liver disease; Antipsychotic agents; Adverse event.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )